文献速递免疫规划妇幼与学校卫生

荷兰孕妇对RSV免疫策略的偏好:混合方法研究

Preferences of Dutch pregnant women for RSV immunisation - a mixed method study.
PubMed 文献 · Vaccine · 2026-02-27

该混合方法研究在荷兰15家产前门诊及一家儿童医院开展,通过问卷(412名孕妇)和焦点小组(12名孕妇)了解孕妇对母婴RSV预防方案的偏好。77.4%(319/412)持积极态度,近90%在明确选择时偏好母亲接种疫苗;保护效力和安全性是最重要因素。

要点

  • 近90%孕妇在明确选择时偏好母亲接种RSV疫苗。
  • 疫苗保护效力和儿童接种安全性是影响偏好的最重要因素。
  • 医护人员建议在决策中起重要作用,且孕妇会因另一选项保护力更高而改变选择。

核心结论

  • 多数孕妇对母亲疫苗或婴儿免疫持积极态度,若获得准确全面信息,可能接受任一RSV预防方案。

研究设计与样本

  • 混合方法研究:横断面调查(2022年3月至2023年3月)在荷兰15家产前门诊及Wilhelmina儿童医院进行,问卷基于5Cs框架;质性研究(2024年1-2月)纳入3个焦点小组。
  • 共412名孕妇完成问卷,12名孕妇参与焦点小组。

主要发现

  • 77.4%(319/412)的孕妇对获得任一RSV预防方案持积极态度。
  • 当被要求明确选择时,近90%的孕妇偏好母亲接种疫苗。
  • 影响偏好的最重要因素是预防RSV疾病和免疫对儿童出生前(宫内)及出生后的安全性。
  • 焦点小组中,医护人员建议被视为决策重要因素,所有女性均提及疫苗安全性、疾病预防与保护持续时间之间的平衡。
  • 若另一选项对RSV的保护力更高,女性会改变选择。

临床怎么用

  • 在推行RSV免疫规划时,应向孕妇提供准确全面的信息,重点说明保护效力和安全性。
  • 医护人员应参与决策支持,帮助孕妇权衡疫苗安全性、疾病预防和保护持续时间。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Implementation of newly approved RSV preventive options is advancing rapidly. Therefore, we examined pregnant women's preferences regarding these RSV preventive options to optimise their implementation in immunisation programmes. METHODS: A mixed method study was conducted including a cross-sectional survey (March 2022 - March 2023) and a qualitative study (January-February 2024) at 15 antenatal clinics and the Wilhelmina Children's Hospital in the Netherlands. The questionnaire was created using the theoretical 5Cs framework about vaccine hesitancy. Utilizing a 10-point rating scale, the importance of several factors influencing preference for maternal or infant immunisation were evaluated and participants were asked which option they would prefer. To further explore factors that influence vaccine decision-making focus groups were performed and analysed using inductive thematic analysis. RESULTS: A total of 412 women completed the questionnaire and 12 women participated in three focus groups. Majority of women (77.4%, 319/412) expressed a positive attitude to obtain either RSV preventive option. When asked for a definite decision, almost 90% of women preferred maternal vaccination. The most important influencing factors were protection against RSV disease and the safety of immunisation for the child before (i.e. in utero) and after birth. During the focus groups, advice of healthcare professionals was considered an important factor in decision making and all women referred to the balance between vaccine safety, prevention of the disease and duration of protection. Women would change their choice to the other option in case the other option has a greater protection against RSV. CONCLUSION: We found that the majority of women have a positive attitude toward receiving either a maternal vaccine or infant immunisation. Therefore, it is likely that Dutch pregnant women would be positive to receive either RSV preventive option, provided they receive accurate and comprehensive information that specifically addresses the factors they consider most important.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Phijffer EWEM, Sivakumar C, van den Hoogen A, et al. Preferences of Dutch pregnant women for RSV immunisation - a mixed method study. Vaccine. 2026. PMID: 41762826. doi:10.1016/j.vaccine.2026.128409

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。